{"id":"NCT03901482","sponsor":"Satsuma Pharmaceuticals, Inc.","briefTitle":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine","officialTitle":"EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-06-24","primaryCompletion":"2020-07-31","completion":"2020-08-13","firstPosted":"2019-04-03","resultsPosted":"2023-06-29","lastUpdate":"2023-06-29"},"enrollment":1201,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine","Migraine With Aura","Migraine Without Aura"],"interventions":[{"type":"DRUG","name":"Dihydroergotamine","otherNames":["Dihydroergotamine Mesylate"]},{"type":"DRUG","name":"Placebos","otherNames":["STS101 Placebo"]}],"arms":[{"label":"STS101 Low Dose","type":"EXPERIMENTAL"},{"label":"STS101 High Dose","type":"EXPERIMENTAL"},{"label":"STS101 Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Study STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine","primaryOutcome":{"measure":"Percentage of Subjects With Freedom From Migraine Headache Pain at 2 Hours Post Dose","timeFrame":"2 Hours Post-Dose","effectByArm":[{"arm":"STS101 Low Dose","deltaMin":69,"sd":null},{"arm":"STS101 High Dose","deltaMin":68,"sd":null},{"arm":"STS101 Placebo","deltaMin":53,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":7},"locations":{"siteCount":117,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":363},"commonTop":["Nasal Discomfort","Dyseusia","Rhinorrhea","Nasal Congestion"]}}